DE60006260D1 - Imidazotriazinderivate als gaba rezeptor-liganden - Google Patents
Imidazotriazinderivate als gaba rezeptor-ligandenInfo
- Publication number
- DE60006260D1 DE60006260D1 DE60006260T DE60006260T DE60006260D1 DE 60006260 D1 DE60006260 D1 DE 60006260D1 DE 60006260 T DE60006260 T DE 60006260T DE 60006260 T DE60006260 T DE 60006260T DE 60006260 D1 DE60006260 D1 DE 60006260D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor ligands
- gaba receptor
- optionally substituted
- derivatives
- imidazotriazine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- XZLIYCQRASOFQM-UHFFFAOYSA-N 5h-imidazo[4,5-d]triazine Chemical class N1=NC=C2NC=NC2=N1 XZLIYCQRASOFQM-UHFFFAOYSA-N 0.000 title 1
- 102000005915 GABA Receptors Human genes 0.000 title 1
- 108010005551 GABA Receptors Proteins 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 102000027484 GABAA receptors Human genes 0.000 abstract 1
- 108091008681 GABAA receptors Proteins 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 150000001602 bicycloalkyls Chemical group 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 150000004892 pyridazines Chemical class 0.000 abstract 1
- 125000005415 substituted alkoxy group Chemical group 0.000 abstract 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9919957.2A GB9919957D0 (en) | 1999-08-23 | 1999-08-23 | Therapeutic agents |
GB9919957 | 1999-08-23 | ||
PCT/GB2000/003199 WO2001014377A1 (en) | 1999-08-23 | 2000-08-17 | Imidazo-triazine derivatives as ligands for gaba receptors |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60006260D1 true DE60006260D1 (de) | 2003-12-04 |
DE60006260T2 DE60006260T2 (de) | 2004-07-29 |
Family
ID=10859670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60006260T Expired - Lifetime DE60006260T2 (de) | 1999-08-23 | 2000-08-17 | Imidazotriazinderivate als gaba rezeptor-liganden |
Country Status (10)
Country | Link |
---|---|
US (1) | US6608062B1 (de) |
EP (1) | EP1212324B1 (de) |
JP (1) | JP2003507479A (de) |
AT (1) | ATE253066T1 (de) |
AU (1) | AU775008B2 (de) |
CA (1) | CA2380452C (de) |
DE (1) | DE60006260T2 (de) |
ES (1) | ES2208404T3 (de) |
GB (1) | GB9919957D0 (de) |
WO (1) | WO2001014377A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB0210127D0 (en) | 2002-05-02 | 2002-06-12 | Merck Sharp & Dohme | Therapeutic agents |
WO2004006956A1 (ja) * | 2002-07-12 | 2004-01-22 | Japan Science And Technology Agency | 脳損傷の予後改善薬とそのスクリーニング方法 |
EP2275095A3 (de) | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese durch modulation des Muscarinrezeptors |
EP2258358A3 (de) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenese mit Acetylcholinesterasehemmer |
JP2009512711A (ja) | 2005-10-21 | 2009-03-26 | ブレインセルス,インコーポレイティド | Pde阻害による神経新生の調節 |
CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
ES2391472T3 (es) | 2005-12-20 | 2012-11-27 | Astrazeneca Ab | Derivados de cinnolina sustituidos como moduladores del receptor de GABAA y método para su síntesis |
US7465795B2 (en) | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
US20100216734A1 (en) | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
JP2009536667A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | 5ht受容体介在性の神経新生 |
AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
KR20090064418A (ko) | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
GB0622472D0 (en) | 2006-11-10 | 2006-12-20 | Addex Pharmaceuticals Sa | Novel heterocyclic derivatives |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
IL310992A (en) * | 2021-08-25 | 2024-04-01 | Ptc Therapeutics Inc | NLRP3 inhibitors |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3422194A (en) | 1967-08-15 | 1969-01-14 | Smithkline Corp | The treatment of depression with imidazo(1,2-b)-as-triazines and compositions thereof |
WO1998004559A2 (en) * | 1996-07-25 | 1998-02-05 | Merck Sharp & Dohme Limited | Substituted triazolo-pyridazine derivatives as ligands for gaba receptors |
JP2002527519A (ja) * | 1998-10-16 | 2002-08-27 | メルク シャープ エンド ドーム リミテッド | Gaba受容体のリガンドとしてのピラゾロトリアジン誘導体 |
-
1999
- 1999-08-23 GB GBGB9919957.2A patent/GB9919957D0/en not_active Ceased
-
2000
- 2000-08-17 WO PCT/GB2000/003199 patent/WO2001014377A1/en active IP Right Grant
- 2000-08-17 ES ES00954717T patent/ES2208404T3/es not_active Expired - Lifetime
- 2000-08-17 CA CA002380452A patent/CA2380452C/en not_active Expired - Fee Related
- 2000-08-17 EP EP00954717A patent/EP1212324B1/de not_active Expired - Lifetime
- 2000-08-17 JP JP2001518708A patent/JP2003507479A/ja not_active Withdrawn
- 2000-08-17 AU AU67077/00A patent/AU775008B2/en not_active Ceased
- 2000-08-17 US US10/069,437 patent/US6608062B1/en not_active Expired - Fee Related
- 2000-08-17 DE DE60006260T patent/DE60006260T2/de not_active Expired - Lifetime
- 2000-08-17 AT AT00954717T patent/ATE253066T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP1212324B1 (de) | 2003-10-29 |
GB9919957D0 (en) | 1999-10-27 |
CA2380452A1 (en) | 2001-03-01 |
ES2208404T3 (es) | 2004-06-16 |
AU6707700A (en) | 2001-03-19 |
WO2001014377A1 (en) | 2001-03-01 |
CA2380452C (en) | 2008-10-28 |
EP1212324A1 (de) | 2002-06-12 |
ATE253066T1 (de) | 2003-11-15 |
US6608062B1 (en) | 2003-08-19 |
DE60006260T2 (de) | 2004-07-29 |
JP2003507479A (ja) | 2003-02-25 |
AU775008B2 (en) | 2004-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9927687D0 (en) | Therapeutic agents | |
DE60016566D1 (de) | Triazolopyridazinderivate als liganden für gaba-rezeptoren | |
ATE253066T1 (de) | Imidazotriazinderivate als gaba rezeptor-liganden | |
DE60214532D1 (de) | Imidazopyrimidin-derivate als liganden für gaba-rezeptoren | |
GB0117277D0 (en) | Therapeutic agents | |
AU1253002A (en) | Imidazo-triazine derivatives as ligands for gaba receptors | |
BG104671A (en) | Triazolo-pyridazine derivatives as ligands for gaba receptors | |
YU2899A (sh) | Supstituisani triazolo-piridazin derivati kao ligandi za gaba receptore | |
GB0212048D0 (en) | Therapeutic agents | |
DE69911374D1 (de) | Triazolopiridazinederivate als gaba rezeptor-liganden | |
BG108166A (en) | Imidazo-pyrimidine derivatives as liigands for gaba receptors | |
ATE255109T1 (de) | Imidazopyridinderivate als gaba rezeptor liganden | |
DE60307462D1 (de) | 8-fluorimidazo(1,2-a)pyridin derivative als liganden für gaba rezeptoren | |
ATE371659T1 (de) | Pyrazolotriazinderivate als gaba-rezeptorliganden | |
DE60325865D1 (de) | Phenylpyridazin derivative als liganden für gaba-rezeptoren | |
PE44299A1 (es) | Derivados sustituidos de triazolo-piridacina como ligandos para receptores gaba | |
CA2260774A1 (en) | Substituted triazolo-pyridazine derivatives as ligands for gaba receptors | |
JO2312B1 (en) | Imidazo-pyrimidine derivatives as associative groups of JABA receptors | |
TR200002100T2 (tr) | GABA reseptörleri için ligandlar olarak triazolo-piridazin türevleri | |
BR0104169A (pt) | Sistema de anel condensado contendo indol como antagonistas aza-antracênicos seletivos do receptor muscarìnico m4 | |
ATE252103T1 (de) | 6-substituierte 1,2,4a,5a,8a,8b-hexahydro- und 1, 2,3,4,4a,5a,8a,8b-oktahydro-6h-pyrrolo(3',4':4, 5)furo(3,2-b)pyrid-8(7h)-on derivate und ihre verwendung zur bekämpfung von endoparasiten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |